CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
60,685,761
Share change
-1,632,002
Total reported value
$109,838,561
Put/Call ratio
31%
Price per share
$1.81
Number of holders
90
Value change
-$9,377,888
Number of buys
57
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q1 2015

As of 31 Mar 2015, CTI BIOPHARMA CORP - COM (CTIC) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,685,761 shares. The largest 10 holders included STATE STREET CORP, FMR LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., MILLENNIUM MANAGEMENT LLC, EAGLE ASSET MANAGEMENT INC, BlackRock Fund Advisors, NORTHERN TRUST CORP, Candriam Luxembourg S.C.A., and TFS CAPITAL LLC. This page lists 90 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.